Triggiani Vincenzo, Ciampolillo Anna, Guastamacchia Edoardo, Licchelli Brunella, Fanelli Margherita, Resta Francesco, Tafaro Emilio
Internal Medicine, Endocrinology and Metabolic Disease, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
Immunopharmacol Immunotoxicol. 2004 May;26(2):215-24. doi: 10.1081/iph-120037717.
Second to diabetes mellitus, thyroid diseases are the most common endocrinopathies seen in pregnancy. The incidence of post-partum thyroid dysfunction (PPTD) in women with type 1 diabetes mellitus is three-fold increased. We determined the incidence of thyroid abnormalities in a well-defined group of young subjects with type 1 diabetes and in an age-matched healthy controls during and six months after pregnancy in an area of mild iodine deficiency. Twenty-five out of twenty-eight pregnant women completed the study. Fifteen were affected by type 1 diabetes and ten were controls. Our protocol of study consisted of four evaluations of each subject: in the first, in the second trimester, at delivery and six months after. At each control the patients were submitted to physical examination, thyroid ultrasonography, and determination of fT3, fT4, TSH, Antithyroglobulin antibodies (TgAbs), Antithyroperoxidase antibodies (TPOAbs). The variation of thyroid volume is statistically significant in both the diabetics and in the controls during the different times of observations. Four out of the fifteen diabetic pregnant patients (27%) developed a thyroid disease: two cases of post-partum thyroiditis (PPT) and two cases of euthyroid benign nodular goiter, as confirmed by cytological examination. Two out ten controls (20%) developed positive antibodies (TPO Abs and TgAbs) since the first observation and showed an autoimmune thyroiditis six months after delivery. Both of them showed a familial history of thyroid disease. Our study suggests that in an area of mild iodine deficiency the incidence of thyroid autoimmunity in pregnant women is similar, whether diabetic or not; moreover, thyroid volume is increasing in the diabetics as much as in the non diabetics during pregnancy.
仅次于糖尿病,甲状腺疾病是孕期最常见的内分泌疾病。1型糖尿病女性产后甲状腺功能障碍(PPTD)的发病率增加了两倍。我们确定了在轻度碘缺乏地区,一组明确的1型糖尿病年轻受试者以及年龄匹配的健康对照在孕期及产后六个月甲状腺异常的发病率。28名孕妇中有25名完成了研究。其中15名患有1型糖尿病,10名是对照组。我们的研究方案包括对每个受试者进行四次评估:第一次在孕早期,第二次在孕中期,第三次在分娩时,第四次在产后六个月。每次检查时,患者都要接受体格检查、甲状腺超声检查,并测定游离三碘甲状腺原氨酸(fT3)、游离甲状腺素(fT4)、促甲状腺激素(TSH)、抗甲状腺球蛋白抗体(TgAbs)、抗甲状腺过氧化物酶抗体(TPOAbs)。在不同观察时间,糖尿病患者和对照组的甲状腺体积变化均具有统计学意义。15名糖尿病孕妇中有4名(27%)患了甲状腺疾病:经细胞学检查确诊,2例为产后甲状腺炎(PPT),2例为甲状腺功能正常的良性结节性甲状腺肿。10名对照组中有2名(20%)自首次观察以来出现抗体阳性(TPO抗体和Tg抗体),并在产后六个月表现为自身免疫性甲状腺炎。她们两人都有甲状腺疾病家族史。我们的研究表明,在轻度碘缺乏地区,无论是否患有糖尿病,孕妇甲状腺自身免疫的发病率相似;此外,孕期糖尿病患者的甲状腺体积增加幅度与非糖尿病患者相同。